JP2023544724A5 - - Google Patents
Info
- Publication number
- JP2023544724A5 JP2023544724A5 JP2023519831A JP2023519831A JP2023544724A5 JP 2023544724 A5 JP2023544724 A5 JP 2023544724A5 JP 2023519831 A JP2023519831 A JP 2023519831A JP 2023519831 A JP2023519831 A JP 2023519831A JP 2023544724 A5 JP2023544724 A5 JP 2023544724A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063086830P | 2020-10-02 | 2020-10-02 | |
| US63/086,830 | 2020-10-02 | ||
| US202063114769P | 2020-11-17 | 2020-11-17 | |
| US63/114,769 | 2020-11-17 | ||
| US202163241891P | 2021-09-08 | 2021-09-08 | |
| US63/241,891 | 2021-09-08 | ||
| PCT/EP2021/077057 WO2022069690A2 (en) | 2020-10-02 | 2021-10-01 | Methods for delivery of psychedelic medications by inhalation and systems for performing the methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023544724A JP2023544724A (ja) | 2023-10-25 |
| JPWO2022069690A5 JPWO2022069690A5 (https=) | 2024-07-29 |
| JP2023544724A5 true JP2023544724A5 (https=) | 2024-07-29 |
Family
ID=78080292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023519831A Pending JP2023544724A (ja) | 2020-10-02 | 2021-10-01 | 吸入による幻覚発動薬の送達方法および方法を実施するためのシステム |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230355583A1 (https=) |
| EP (1) | EP4221682A2 (https=) |
| JP (1) | JP2023544724A (https=) |
| KR (1) | KR20230079351A (https=) |
| AU (1) | AU2021354006A1 (https=) |
| CA (1) | CA3194558A1 (https=) |
| WO (1) | WO2022069690A2 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201907871D0 (en) | 2019-06-03 | 2019-07-17 | Small Pharma Ltd | Therapeutic compositions |
| CN114787363A (zh) | 2019-10-01 | 2022-07-22 | 恩派瑞安神经科学公司 | 对真菌进行遗传工程化以调节色胺表达 |
| JP7422473B2 (ja) | 2019-11-07 | 2024-01-26 | サイビン ユーケー リミテッド | 合成方法 |
| KR20240096817A (ko) | 2020-05-19 | 2024-06-26 | 사이빈 아이알엘 리미티드 | 중수소화된 트립타민 유도체 및 사용 방법 |
| US11773062B2 (en) | 2021-03-22 | 2023-10-03 | Small Pharma Ltd | Deuterated compounds |
| US12042564B2 (en) | 2020-06-02 | 2024-07-23 | Cybin Uk Ltd | Therapeutic solid dosage forms |
| US12122741B2 (en) | 2020-08-18 | 2024-10-22 | Cybin Irl Limited | Therapeutic phenethylamine compositions and methods of use |
| US11406619B2 (en) | 2020-08-28 | 2022-08-09 | Small Pharma Ltd | Injectable formulations |
| US12521370B2 (en) | 2020-12-01 | 2026-01-13 | Cybin Uk Ltd | Inhalable formulations |
| US11660289B2 (en) | 2020-12-01 | 2023-05-30 | Small Pharma Ltd. | Deuterated or partially deuterated N,N-dimethyltryptamine compounds |
| US12492178B2 (en) | 2021-09-01 | 2025-12-09 | Empathbio, Inc. | Stable polymorph of R-MDMA HCl |
| US11697638B2 (en) | 2021-09-08 | 2023-07-11 | Small Pharma Ltd | 5-methoxy-N,N-dimethyltryptamine crystalline forms |
| US12318477B2 (en) | 2021-11-18 | 2025-06-03 | Cybin Uk Ltd | Injectable and inhalable formulations |
| US11912680B2 (en) | 2021-12-28 | 2024-02-27 | Empathbio, Inc. | Nitric oxide releasing prodrugs of MDA and MDMA |
| EP4457336A4 (en) | 2021-12-31 | 2026-01-14 | Empyrean Neuroscience Inc | ORGANISMS GENETICALLY MODIFIED TO PRODUCE PSYCHOTROPIC ALKALOIDS |
| US20250051279A1 (en) * | 2022-01-14 | 2025-02-13 | Cybin Irl Limited | Tryptamine compositions and methods |
| WO2023168023A1 (en) | 2022-03-04 | 2023-09-07 | Reset Pharmaceuticals, Inc. | Co-crystals or salts comprising psilocin |
| AU2023246690A1 (en) * | 2022-03-31 | 2024-11-07 | Cybin Irl Limited | Methods for delivery of psychedelic medications by inhalation and systems for performing the methods |
| CN120344243A (zh) * | 2022-10-13 | 2025-07-18 | 赛本英国有限公司 | 包含致幻剂的胃肠外制剂的施用方法 |
| EP4601638A2 (en) * | 2022-10-14 | 2025-08-20 | ATAI Therapeutics, Inc. | Acetal, ketal, and hemiaminal analogs of psilocin, processes for the preparation thereof, and methods of use |
| US12280216B2 (en) | 2023-02-01 | 2025-04-22 | Thomas E. Garrison | Mixtures including nitrous oxide |
| US11980717B1 (en) * | 2023-02-01 | 2024-05-14 | Thomas E. Garrison | Mixtures including nitrous oxide |
| WO2025010308A2 (en) * | 2023-07-03 | 2025-01-09 | Empathbio, Inc. | Mdma enantiomer compositions and methods for modulating aggression response |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7267121B2 (en) | 2004-04-20 | 2007-09-11 | Aerogen, Inc. | Aerosol delivery apparatus and method for pressure-assisted breathing systems |
| CN104906669A (zh) * | 2007-03-30 | 2015-09-16 | 菲利普莫里斯生产公司 | 用于输送药剂的装置和方法 |
| MA50786A (fr) * | 2017-10-26 | 2022-04-27 | Blumentech S L | Produit d'association pour le traitement de troubles neurologiques et/ou psychiatriques |
| EP4353314A3 (en) * | 2019-02-22 | 2024-07-03 | GH Research Ireland Limited | 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) for treating major depression |
| RU199823U1 (ru) | 2020-06-10 | 2020-09-21 | Общество С Ограниченной Ответственностью "Центр Передовых Радиационных Медицинских И Биологических Технологий | Устройство для лечения бронхолегочных заболеваний |
-
2021
- 2021-10-01 JP JP2023519831A patent/JP2023544724A/ja active Pending
- 2021-10-01 CA CA3194558A patent/CA3194558A1/en active Pending
- 2021-10-01 WO PCT/EP2021/077057 patent/WO2022069690A2/en not_active Ceased
- 2021-10-01 EP EP21786852.0A patent/EP4221682A2/en active Pending
- 2021-10-01 AU AU2021354006A patent/AU2021354006A1/en active Pending
- 2021-10-01 US US18/027,810 patent/US20230355583A1/en active Pending
- 2021-10-01 KR KR1020237007858A patent/KR20230079351A/ko active Pending